HKSE · 2041.HK · HKD
Stock price
Quote as of Oct 30, 2026, 08:08 AM UTC. Cached market data; not a live quote.
One-year closing-price history · HKD. Historical prices are not a forecast.
Medcaptain Medical Technology Co. Ltd. Class H’s quoted price sits in the lower half of its reported 52-week range, 42.94% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Medcaptain Medical Technology Co., Ltd. manufactures integrated perioperative medical devices in China, Europe, Asia, the Middle East, Africa, North America, and South America. It offers life support products, such as infusion systems, medication delivery products, anesthesia machines and vaporizers, workstations, imaging equipment, and other life support products, including airway management, pulmonary function testing devices, deep vein thrombosis (DVT) preventive pumps, vein illuminators, monitors, and veterinary life support products; minimally invasive intervention products, such as an endoscopic product portfolio for the diagnosis and treatment of conditions relating to the digestive system, including the gastrointestinal (GI) and hepatobiliary tracts, and the urological system; and In Vitro diagnostics products, such as thromboelastography analyzers, blood grouping analyzers, chemiluminescent immunoassay (CLIA) testing analyzers and reagent kits, and molecular diagnostics equipment and testing kits. The company sells its products through a chain of distributors globally. Medcaptain Medical Technology Co., Ltd. was formerly known as Shenzhen Yusheng Medical Technology Co., Ltd. and changed its name to Medcaptain Medical Technology Co., Ltd. in July 2023. Medcaptain Medical Technology Co., Ltd. was incorporated in 2011 and is based in Shenzhen, China.
Latest available per-share figures in HKD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:16 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
HK$3.22-HK$0.02 (-0.46%)
Shandong Weigao Group Medical Polymer Company Limited’s quoted price sits in the lower half of its reported 52-week range, 44.76% below the high.
HK$1.47-HK$0.08 (-5.16%)
LifeTech Scientific Corporation’s quoted price sits in the lower half of its reported 52-week range, 38.24% below the high.
HK$18.64-HK$0.58 (-3.02%)
Zylox-Tonbridge Medical Technology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 33.43% below the high.
HK$30.00+HK$0.36 (+1.21%)
Shanghai Kindly Medical Instruments Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 27.54% below the high.
HK$13.15-HK$1.10 (-7.72%)
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 33.59% below the high.
HK$51.00-HK$3.25 (-5.99%)
Star Sports Medicine Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 82.94% below the high.
HK$53.20+HK$0.25 (+0.47%)
Shanghai HeartCare Medical Technology Corporation Limited’s quoted price sits in the upper half of its reported 52-week range, 20.48% below the high.
HK$1.81+HK$0.01 (+0.56%)
Sisram Medical Ltd’s quoted price sits in the lower half of its reported 52-week range, 63.24% below the high.
